View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Simen Mortensen
  • Simen Mortensen

Bonava (Hold, TP: SEK9.50) - No KPI recovery in Q1

As expected, Bonava reported close to zero EBIT and EPS. Moreover, the leading KPIs for starts and sales were weaker than expected, and we have cut our 2026e EPS. We continue to expect close to zero EPS in 2024–2026e, but with a P/B of c0.4x and refinancing in place with the Q1 equity issue, we believe the negatives are reflected in the share price. We reiterate our HOLD, but have raised our target price to SEK9.5 (8.5).

Simen Mortensen
  • Simen Mortensen

Jm Ab (Sell, TP: SEK155.00) - Q1 EPS miss

Higher tax costs than forecast meant Q1 EPS missed expectations. Sales of new homes were broadly in line with our estimate – but starts were below, prompting us to cut our 2024e EPS by c19% and 2025e by c5%. However, expecting a catch-up effect, we have raised our 2026e EPS by c16%. In our view, the valuation is already pricing in a market recovery, while we still see a risk of setbacks, mainly from fewer and slower interest rate cuts, and we see a better risk/reward elsewhere in the sector. We ...

Simen Mortensen
  • Simen Mortensen

Entra (Hold, TP: NOK105.00) - Continued asset value decline

Entra reported weaker underlying Q1 results than we expected, as well as still-declining asset values (-2.5% QOQ) due to higher yield valuations. On increased market interest rates, we have cut our 2024–2026e FFO by c12–16%. We reiterate our HOLD, but have lowered our target price to NOK105 (115).

Simen Mortensen
  • Simen Mortensen

Norconsult (Buy, TP: NOK31.50) - Billing ratio in focus

With Easter in Q1, the billable working days in the quarter were 60 versus 65 last year. Thus, we expect a YOY drop in adj. EBIT of c55%. Our Q1 focus point is the billing ratio, with new hires in Sweden ramping up and Building demand in regional Norway levelling out as the main moving parts. For 2026, consensus EBIT seems too bullish, given few 2026e working days. However, the long-term story remains intact in our view, despite this potential consensus downside. We reiterate our BUY and NOK31.5...

Simen Mortensen
  • Simen Mortensen

Multiconsult (Buy, TP: NOK160.00) - On course for Q1e consensus beat

While Easter falling in Q1 is set to lead to a YOY EBIT drop on fewer working days, we expect a consensus beat, assuming a continuation of Q4’s high billing ratio. With property markets still weak, the recent EPBD revision is likely to represent a long-term boost for the company. We reiterate our BUY and NOK160 target price.

Simen Mortensen
  • Simen Mortensen

EPBD the big story this week

The Energy Performance of Buildings Directive (EPBD) was approved on 12 April, requiring the modernisation of existing real estate in the EU, and will soon enter the Official Journal of the EU. In other news, KMC Properties bought a new asset and appointed an interim CEO, JM got a new CEO, while Castellum announced a divestment and new leases, and Atrium Ljungberg kicked off Q1 reporting season. The weighted-average implied EBITDA yields on the stocks we cover are 4.74% for 2024e and 5.01% for 2...

Simen Mortensen
  • Simen Mortensen

Renovation rules now a reality

The Energy Performance of Buildings Directive (EPBD) was approved on 12 April, requiring the modernisation of existing real estate in the EU, and will soon enter the Official Journal of the EU. Member states will have two years to incorporate the provisions into their national legislation. While Q1 is Nordic construction’s low season due to winter effects, we see some downside risk to Q1e consensus and longer-term to 2024–2026e EBIT on lower development gains. We recommend a stock-picking approa...

Simen Mortensen
  • Simen Mortensen

Ncc (Buy, TP: SEK150.00) - Q1 was cold

With a harsh Nordic winter and Easter falling in Q1, we expect a larger seasonal loss than consensus (results due at c07:00 CET on 3 May). We expect NCC to record one commercial property divestment of SEK530m, but due the level of announced orders, we have reduced our 2024–2026e revenue and EPS and expect Q1 order intake below Infront consensus. We reiterate our BUY and NOK150 target price.

Simen Mortensen
  • Simen Mortensen

Skanska (Buy, TP: SEK225.00) - Solid Q1 order intake expected

With no asset divestments of Commercial Development (CD) projects, we expect Q1 group EBIT to be below Infront consensus (results due at c07:30 CET on 8 May). However, with the strong announced orders, we expect a beat on order intake. KPIs in Residential Development (RD) are likely to be weak, we believe, but up from the all-time lows last year. We reiterate our BUY and SOTP-based target price of SEK225.

Simen Mortensen
  • Simen Mortensen

Peab (Sell, TP: SEK58.00) - Consensus too bullish, too soon

With solid announced orders in Q1, we expect order intake above consensus, but EBIT below due to the cold Nordic winter and early Easter (results due 6 May (time TBA)). We also believe consensus is too bullish on the speed of Property Development’s recovery. We find the recent share price rally an overreaction and have downgraded to SELL (HOLD), with a raised target price of SEK58 (52), reflecting our updated estimates and peer valuation.

Simen Mortensen
  • Simen Mortensen

NRC Group (Buy, TP: NOK15.00) - New CEO’s plan in focus

NRC’s Q1s tend to be its low season, due to the Nordic winter effects, and we expect a seasonal loss in EBIT (results due at c07:00 CET on 25 May). However, announced order intake has been strong, including the order termination and excluding the EUR344m light rail alliance contract in Finland. In conjunction with the Q1 results, NRC is due to host a CMD, where the new CEO will present the new group strategy. We continue to see strong upside potential on an EBIT margin recovery and reiterate our...

Simen Mortensen
  • Simen Mortensen

Fully valued near-term

We maintain a neutral sector stance, but see near-term setbacks and consider risks tilted to the downside near-term due to strong sector performance in the past month, while market interest rates have risen. We expect two years of zero NAV growth, on average, due to yield expansion, and the sector theme to be deleveraging, with limited capex. We see few potential company-specific catalysts, leaving share prices largely driven by macro factors. We consider the sector fully valued near-term, at an...

Simen Mortensen
  • Simen Mortensen

Vacancy uptick in Stockholm

This week, Citymark announced vacancies in the Stockholm office market are now higher than during the 2007–2008 financial crisis. Selvaag Bolig (SELL, TP NOK25) released KPIs for Q1, where unsold inventory was at an all-time high. Norwegian house prices rose 0.9% in March and 5.9% YTD. Entra announced leases. Corem announced that it aims to issue bonds. The weighted-average implied EBITDA yields on the stocks we cover are 4.62% for 2024e and 4.88% for 2025e.

Simen Mortensen
  • Simen Mortensen

Selvaag Bolig (Sell, TP: NOK25.00) - Inventory spike set to delay prof...

In its Q1 KPI update, sold homes were marginally above our forecast, helped by sales to its main owner. However, of the 236 completed units, only 179 were delivered to clients. Unsold inventory climbed to an all-time high of 126 units at end-Q1 (ATH), and 56 completed sold homes are pending delivery. Due to the inventory build-up, we have cut our 2024e EPS by c29%, but have raised 2025e EPS by c42.5%. We reiterate our SELL and NOK25 target price.

Simen Mortensen
  • Simen Mortensen

Veidekke (Hold, TP: NOK120.00) - Low season ahead

Due to Nordic winter effects, Q1 typically marks low season for Veidekke. We are below consensus on Q1e EBIT, forecasting a low-season nominal loss. We expect reduced long-term civil engineering spending in Norway following publication of the new National Transport Plan (NTP), but with a weaker NOK, our 2024–2026e EPS are broadly unchanged. We have raised our target price to NOK120 (115) to reflect higher peer multiples, but reiterate our HOLD.

Simen Mortensen
  • Simen Mortensen

AF Gruppen (Sell, TP: NOK100.00) - Expectations look too high

We continue to see downside risk to consensus, both short-term ahead of the Q1 results (due at 07:00 CET on 15 May) and longer-term (2024–2026e). After a 2023 EBIT margin of 2.5%, consensus is for 4.8% in 2024 and 5.2% in 2025. We believe this is too optimistic, and reiterate our SELL. However, we have raised our target price to NOK100 (95) on increased peer valuation.

Simen Mortensen
  • Simen Mortensen

Transactions, debt repurchase, and National Transport Plan

This week, Corem, Catena and Vasakronan (which re-entered the M&A arena after a more than 5-year absence) announced property transactions, SBB saw its share price rise by 29% on the week after retiring long-term debt, and the Norwegian government unveiled a somewhat smaller budget in its latest National Transport Plan (NTP), with a weak read-across to the local construction and consultancy sector, in our view The weighted-average implied EBITDA yields on the stocks we cover are 4.54% for 2024e a...

Simen Mortensen
  • Simen Mortensen

Insider transactions, SBB rating lowered and lease contracts

There were several insider transactions this week. Also, SBB offered to buy back certain hybrid and senior bonds, and credit agencies lowered their ratings in response. Corem announced new leases, and a large Norwegian real estate syndicate was taken over by one of its bondholders. The weighted-average implied EBITDA yields on the stocks we cover are 4.60% for 2024e and 4.86% for 2025e.

Simen Mortensen
  • Simen Mortensen

Jm Ab (Sell, TP: SEK155.00) - Hockey-stick recovery unlikely

The share price has rallied on the peak interest rate narrative, improved consumer sentiment and short covering, but new housing sales remain weak QTD. We expect Q1 profit to miss Infront consensus on price cuts, but starts to be above (results due at 08:00 CET on 23 April). Overall, we believe the share price has run too far ahead of the recovery and profit lead times are much longer than reflected in market expectations. We reiterate our SELL, but have raised our target price to SEK155 (130).

Simen Mortensen
  • Simen Mortensen

YIT (Sell, TP: EUR1.40) - A bandage, not a remedy

This morning, YIT announced a refinancing package of EUR100m in liquidity from new equity, a convertible bond and delayed loan amortisations. While this removes the near-term liquidity risk, we believe it remains overleveraged and should continue to focus on further divestments and reducing debt. With a weak market, we still expect low nominal EPS, having further reduced our 2024–2026e on the increased share count and funding cost assumptions. We reiterate our SELL and EUR1.4 target price.

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch